A Feasibility Study for Examination the Use of Brain Prefrontal Activity Monitoring, for Early Detection of Migraine Attack
试验速览
- 阶段
- 不适用
- 入组人数
- 50
- 试验地点
- 1
- 主要终点
- Measurements of brain electrical signal in Micro volt.
研究概览
简要总结
This study evaluates the use of brain activity monitoring for prediction of migraine attacks in an expected time scale of 12-48 hours prior to the migraine attack.
详细描述
The study will be conducted in one are. Participants diagnosed with migraine, will be evaluated for their EEG characteristics as well as daily migraine related clinical and general status. Participants' monitoring will be conducted for 20 times for a duration of one month.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 50 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosed with migraine by a neurologist.
- •Male or Female, aged 18 -50 years.
- •Able and willing to comply with all study requirements.
- •Having 3-10 migraine attacks per month.
排除标准
- •Diagnosed with chronic pain, neurological or psychiatric disorders.
- •Current or past use of anti-depressants.
- •A user of recreational or illicit drugs or has had a recent history of drug or alcohol abuse or dependence.
- •History of seizures
- •Head injury with consciousness loss in the last three months.
- •Diagnosed as ADHD and/or use of Ritalin.
- •Hearing disorder and/or known ear drum impairment.
- •Having migraine attacks occurring only during the menstruation.
研究组 & 干预措施
Participants diagnosed with migraine
EEG monitoring (MindWave by NeuroSky and EPOC by Emotiv)
干预措施: EEG monitoring (MindWave by NeuroSky) (Device)
Participants diagnosed with migraine
EEG monitoring (MindWave by NeuroSky and EPOC by Emotiv)
干预措施: EEG monitoring (EPOC by Emotiv) (Device)
结局指标
主要结局
Measurements of brain electrical signal in Micro volt.
时间窗: 1 months
Measurements of brain electrical signal in Micro volt will be quantified by an algorithm and correlated to reported migraine cycle (as reported by migraine patients in questionnaires).
次要结局
未报告次要终点